09/18/2017 - 4:34pm

Solosec is the first approved single-dose oral therapy for bacterial vaginosis. 

09/12/2017 - 4:22pm
Recently, patient advocates and regulators have begun acknowledging a need for something to be done about increasing costs of specialty drugs — both for manufacturers and patients. 
 
09/12/2017 - 2:07pm

The legislation aims to make it easier for generics makers to access drug samples of branded products when trying to develop a generic version, many of which are protected by Risk Evaluation and Management Strategies,

09/11/2017 - 12:11pm

Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO. 

09/08/2017 - 12:11pm
The approval means that Admelog has met all requirements for the regulatory agency, pending any patent issues that have not yet been resolved. 
09/05/2017 - 3:28pm

The company has named its current global head of drug development and chief medical officer, Dr. Vasant Narasimhan, as CEO, effective Feb. 1, 2018.

09/05/2017 - 12:08pm

Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a Food and Drug Administration decision date of Nov. 29.

08/31/2017 - 2:40pm

Baricitinib is a once-daily oral investigational medication for the treatment of patients with moderate-to-severe rheumatoid arthritis.

08/31/2017 - 2:14pm

Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.